Patients with cancer should receive a tailored exercise prescription to protect their heart, reported a paper published in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).
A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma for five years or more in one in two patients, according to a study led by The Royal Marsden UK MHS Foundation Trust
New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer. Results of the BEACON CRC Phase III trial have shown that triple therapy targeting BRAF mutations in progressive metastatic colorectal tumors significantly improved overall survival and objective response compared to standard care.
"Patients who were seen in an emergency department that was not associated with where they received cancer treatment or one of the 14 major cancer centers in Ontario Province of Canada were less likely to be admitted to hospital but more likely to die within 30 days of the visit," said Dr. Keerat Grewal, an emergency physician at Mount Sinai Hospital, and the University of Toronto.
Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids — and which might only suffer their side effects — with help from a dozen clinical variables researchers have identified using machine learning techniques.